Hematologic Medications and GI Medications Flashcards
Whole blood completion time
2-4 hours
Whole blood therapeutic use
Restore volume
Whole blood reaction monitoring (6)
- Acute hemolytic
- Fever
- Anaphylactic
- Mild allergic
- Hypervolemia
- Sepsis
Packed RBCs completion time
2-4 hours
Packed RBCs therapeutic uses (5)
- Increases available RBC
- Severe anemia
- Hemoglobinopathies
- Hemolytic anemias
- Erythroblastosis fetalis
Packed RBCs reaction monitoring (5)
- Acute hemolytic
- Fever
- Anaphylactic
- Mild allergic
- Sepsis
Platelets completion time
15-30 minutes
Platelets therapeutic uses (5)
- Increased platelet count
- Active bleeding
- Thrombocytopenia
- Aplastic anemia
- Bone marrow suppression
Platelets reaction monitoring (2)
- Fever
- Sepsis
FFP completion time
30-60 minutes
FFP therapeutic uses
Replace clotting factors
FFP reaction monitoring (6)
- Acute hemolytic
- Fever
- Anaphylactic
- Mild allergic
- Hypervolemia
- Sepsis
Pheresed granulocytes completion time
45-60 minutes
Pheresed granulocytes therapeutic use (3)
- Severe neutropenia
- Neonatal sepsis
- Neutrophil dysfunction
Pheresed granulocytes reaction monitoring (6)
- Acute hemolytic
- Febrile
- Anaphylactic
- Mild allergic
- Hypervolemia
- Sepsis
Albumin 5% completion time
1-10ml/min
Albumin 25% completion time
4ml/min
Albumin therapeutic use (6)
- Expand volume by oncotic changes
- Hypovolemia
- Hypoalbuminemia
- Burns
- Severe nephrosis
- Hemolytic disease in newborns
Albumin reaction monitoring (2)
- Hypervolemia
- Pulmonary edema
Nursing interventions for blood product administration (6)
- Verify patient’s ID, name, blood type by 2 nurses
- Obtain baseline vitals
- IV access with 18-20 gauge catheter
- Prime tubing with 0.9% sodium chloride
- Stay with patient for first 15 minutes to monitor for signs of a reaction
- Complete infusion within 4 hours
Blood product reaction management (4)
- Stop infusion and take vitals
- Infuse 0.9% sodium chloride
- Notify provider
- Follow protocol for sending urine sample, CBC, bag/tubing to lab for analyzing
Hematopoietic growth factor action
Stimulate bone marrow to make specific blood cells
Hematopoietic growth factor medications (4)
- Epoietin alfa
- Filgrastim
- Pegfilgrastim
- Oprelvekin
Epoeitin alfa therapeutic use (2)
- Stimulate RBC production
- Anemia from chronic kidney disease, Retrovir therapy, chemo
Epoietin alfa side/adverse effects
- HTN
Epoietin alfa nursing interventions (3)
- Give subQ or IV
- Don’t agitate vial
- Monitor hematocrit/hemoglobin
Filgrastim/pegfilgrastim therapeutic uses (2)
- Stimulate WBC production
- Neutropenia due to cancer
Filgrastim/pegfilgrastim side/adverse effects (2)
- Bone pain
- Leukocytosis
Filgrastim/pegfilgrastim nursing interventions (3)
- SubQ/IV
- Don’t agitate vial
- Monitor CBC
Oprelvekin therapeutic uses (2)
- Stimulate platelet production
- Thrombocytopenia due to cancer
Oprelvekin side/adverse effects (3)
- Fluid retention
- Blurred vision
- Cardiac dysrhythmias
Oprelvekin nursing interventions (2)
- Give 6-24 hours after chemo
- SubQ
Oral iron nursing interventions (4)
- Dilute liquid with juice/water and give straw/syringe to avoid contact with the teeth
- Encourage orange juice fortified with vitamin C
- Avoid antacids, coffee, tea, dairy products, whole grain bread concurrently and 1 hour after giving due to decreased absorption
- Monitor for constipation and GI upset
IM iron nursing interventions (4)
- Use large bore needle 19-20 gauge 3 inch
- Change needle after drawing up from vial
- Z track method in ventrogluteal, never deltoid
- Don’t massage injection site